ARCHIVES

Letter to the Editor: Gensia Official Says No “Threat” Implied In Question Study

This article is from The Cancer Letter archive.

Vol. 21 No. 21 | May 26, 1995

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013

NCI Programs: Institute To Contact For Software To Control Ultrasound Imaging

November 19, 1999

Drug Discovery Group Announcement Issued

January 7, 1983

NCAB Subcommittee Suggests Comp Centers Must Have Core Grants

September 22, 1978

Murray Copeland Display Dedicated

March 18, 1983

In Congress: Mack Urges Stevens To Add $2 Billion To NIH Appropriations

June 13, 1997